Single-Cell Analysis of Signaling Proteins Provides Insights into Proapoptotic Properties of Anticancer Drugs

• Published in: Analytical chemistry (Washington) Vol. 92; no. 18; pp. 12498 - 12508
• Main Authors: Wen, Yanrong, Liu, Jia, He, Hui, Li, Shawn S.C, Liu, Zhen
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 15.09.2020
• Subjects: Actinomycin; Analytical chemistry; Anticancer properties; Antineoplastic Agents - chemistry; Antineoplastic Agents - pharmacology; Antineoplastic drugs; Antitumor agents; Apoptosis; Apoptosis - drug effects; Cancer; Caspase 3 - analysis; Caspase 3 - metabolism; Caspase-3; Cell Line; Cell Proliferation - drug effects; Cell Survival - drug effects; Cytochrome; Cytochrome c; Cytochromes; Cytochromes c - analysis; Cytochromes c - metabolism; Cytotoxicity; Dactinomycin - chemistry; Dactinomycin - pharmacology; Deoxyribonucleic acid; DNA; Drug Screening Assays, Antitumor; Drugs; Humans; Immunoassay; Kinetics; Metformin; Metformin - chemistry; Metformin - pharmacology; Particle Size; Plasmonics; Precision medicine; Proteins; Signaling; Single-Cell Analysis; Surface Properties; Survivin; Technology assessment
• ISSN: 0003-2700; 1520-6882
• DOI: 10.1021/acs.analchem.0c02344

Single-cell DNA analysis technology has provided unprecedented insights into many physiological and pathological processes. In contrast, technologies that allow protein analysis in single cells have lagged behind. Herein, a method called single-cell Plasmonic ImmunoSandwich Assay (scPISA) that is capable of measuring signaling proteins and protein complexes in single living cells is described. scPISA is straightforward, comprising specific in-cell extraction and ultrasensitive plasmonic detection. It is applied to evaluate the efficacy and kinetics of cytotoxic drugs. It reveals that different drugs exhibit distinct proapoptotic properties at the single-cell level. A set of new parameters is thus proposed for comprehensive and quantitative evaluation of the efficacy of anticancer drugs. It discloses that metformin can dramatically enhance the overall anticancer efficacy when combined with actinomycin D, although it itself is significantly less effective. Furthermore, scPISA reveals that survivin interacts with cytochrome C and caspase-3 in a dynamic fashion in single cells during continuous drug treatment. As compared with conventional assays, scPISA exhibits several significant advantages, such as ultrahigh sensitivity, single-cell resolution, fast speed, and so on. Therefore, this approach may provide a powerful tool for wide, important applications from basic research to clinical applications, particularly precision medicine.